Last Updated

22 Dec 2020

ImmunoCoV: Host immune responses to SARS-CoV-2

Objectives

Host immune responses to SARS-CoV-2: correlating kinetics with the natural history of infection.

Aims to:

  1. Test and validate antibody and other immunological assays for the diagnosis and further research on the immunology of SARS-CoV-2 infections in African populations, and
  2. Provide detailed kinetics of the immune response to SARS-CoV-2 in relation to viral shedding, clinical symptoms and asymptomatic infections 

Principal Institution(s)

Principal Investigator
Partners
Funding Information
Original Currency €497300

Related Resources
Multimedia
|

ASTMH 2019, Busiku Hamainza: "Data for decision-making—adapting lessons learned from elimination settings to high burden areas"

American Society of Tropical Medicine and Hygiene (ASTMH)

Report
|

WHO Technical consultation on the role of parasite and anopheline genetics in malaria surveillance

World Health Organization (WHO)

Related Projects

- | $31M | 2 subprojects

Malaria Elimination in Southern Africa (Elimination 8)
Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM), Southern Africa Malaria Elimination Eight Initiative Secretariat | Kudzai Makomva | Angola, Botswana, Mozambique, Namibia, South Africa, Swaziland, Zambia, Zimbabwe
-

Application of a community-based and integrated strategy to reduce malaria burden in rural Tanzania
Department for International Development (DFID), UK, Ifakara Health Institute (IHI), Tanzania | Prosper Chaki | Tanzania
Thematic Categories
Surveillance

Date

2020 Jul - 2022 Jul

Total Project Funding

$607,070

Funding Details

$607,070
Original Currency €497300
Project Site
Kenya

Deep Dives

Clinical Epidemiology of COVID-19 in Malaria Settings (ongoing)